Amarin Corp Price/Book
What is the Price/Book of Amarin Corp?
The Price/Book of Amarin Corp is 0.90
What is the definition of Price/Book?
Price to book ratio represents the ratio between a company’s stock value and the book value per share.
mrq (most recent quarter)
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book of companies in the Health Care sector on NASDAQ compared to Amarin Corp
What does Amarin Corp do?
amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.
Companies with price/book similar to Amarin Corp
- India Steel Works has Price/Book of 0.90
- Galapagos NV has Price/Book of 0.90
- Cipher Pharmaceuticals has Price/Book of 0.90
- Jiangsu Expressway has Price/Book of 0.90
- Allreal AG has Price/Book of 0.90
- CITIC Telecom International has Price/Book of 0.90
- Amarin Corp has Price/Book of 0.90
- CESC has Price/Book of 0.90
- Western Asset Investment Grade Defined Opportunity Trust Inc has Price/Book of 0.90
- Macquarie Global Infrastructure Total Return Fund Inc has Price/Book of 0.90
- Hollysys Automation Technologies Ltd has Price/Book of 0.90
- Van Elle plc has Price/Book of 0.90
- Warren Tea has Price/Book of 0.90